Waverly Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Buy |
85,970
+28,502
| +50% | +$1.66M | 0.04% | 402 |
|
|
2025
Q4 | $3.1M | Buy |
57,468
+13,939
| +32% | +$671K | 0.03% | 485 |
|
|
2025
Q3 | $1.96M | Buy |
43,529
+4,006
| +10% | +$187K | 0.02% | 516 |
|
|
2025
Q2 | $1.83M | Buy |
39,523
+126
| +0.3% | +$6.18K | 0.02% | 509 |
|
|
2025
Q1 | $2.4M | Buy |
39,397
+7,298
| +23% | +$425K | 0.03% | 440 |
|
|
2024
Q4 | $1.82M | Buy |
32,099
+18,722
| +140% | +$1.05M | 0.03% | 406 |
|
|
2024
Q3 | $692K | Buy |
13,377
+6
| +0% | +$281 | 0.01% | 517 |
|
|
2024
Q2 | $555K | Buy |
13,371
+1,011
| +8% | +$45.2K | 0.01% | 557 |
|
|
2024
Q1 | $670K | Buy |
12,360
+1,316
| +12% | +$67K | 0.02% | 426 |
|
|
2023
Q4 | $567K | Buy |
11,044
+559
| +5% | +$29.3K | 0.02% | 281 |
|
|
2023
Q3 | $609K | Buy |
10,485
+1,078
| +11% | +$66.1K | 0.03% | 239 |
|
|
2023
Q2 | $602K | Sell |
9,407
-9,806
| -51% | -$658K | 0.03% | 225 |
|
|
2023
Q1 | $1.33M | Sell |
19,213
-1,229
| -6% | -$86.7K | 0.07% | 124 |
|
|
2022
Q4 | $1.47M | Buy |
20,442
+10,651
| +109% | +$803K | 0.08% | 108 |
|
|
2022
Q3 | $696K | Buy |
9,791
+5,328
| +119% | +$386K | 0.05% | 132 |
|
|
2022
Q2 | $343K | Sell |
4,463
-122
| -3% | -$9.29K | 0.03% | 157 |
|
|
2022
Q1 | $335K | Sell |
4,585
-775
| -14% | -$52K | 0.03% | 151 |
|
|
2021
Q4 | $358K | Buy |
5,360
+775
| +17% | +$45.5K | 0.03% | 146 |
|
|
2021
Q3 | $272K | Buy |
4,585
+55
| +1% | +$3.62K | 0.02% | 180 |
|
|
2021
Q2 | $306K | Buy |
4,530
+263
| +6% | +$17.1K | 0.03% | 151 |
|
|
2021
Q1 | $286K | Buy |
4,267
+639
| +18% | +$39.8K | 0.03% | 138 |
|
|
2020
Q4 | $218K | Buy |
+3,628
| New | +$223K | 0.02% | 144 |
|
|
2020
Q3 | – | Sell |
-3,195
| Closed | -$202K | – | 146 |
|
|
2020
Q2 | $202K | Buy |
+3,195
| New | +$191K | 0.03% | 147 |
|
|
2020
Q1 | – | Sell |
-3,128
| Closed | -$210K | – | 148 |
|
|
2019
Q4 | $210K | Buy |
+3,128
| New | +$179K | 0.03% | 128 |
|
|
2018
Q4 | – | Sell |
-11,480
| Closed | -$713K | – | 128 |
|
|
2018
Q3 | $713K | Buy |
11,480
+6
| +0.1% | +$356 | 0.11% | 100 |
|
|
2018
Q2 | $635K | Buy |
11,474
+7
| +0.1% | +$378 | 0.1% | 107 |
|
|
2018
Q1 | $725K | Sell |
11,467
-6,236
| -35% | -$401K | 0.12% | 98 |
|
|
2017
Q4 | $1.08M | Buy |
17,703
+1,089
| +7% | +$68.1K | 0.15% | 91 |
|
|
2017
Q3 | $1.06M | Sell |
16,614
-373
| -2% | -$21.8K | 0.23% | 81 |
|
|
2017
Q2 | $947K | Buy |
16,987
+1,883
| +12% | +$102K | 0.24% | 79 |
|
|
2017
Q1 | $821K | Buy |
15,104
+11,127
| +280% | +$610K | 0.22% | 84 |
|
|
2016
Q4 | $232K | Buy |
+3,977
| New | +$217K | 0.09% | 97 |
|
|
2016
Q1 | – | Sell |
-6,154
| Closed | -$423K | – | 101 |
|
|
2015
Q4 | $423K | Buy |
6,154
+5,945
| +2,844% | +$393K | 0.18% | 63 |
|
|
2015
Q3 | $12K | Hold |
209
| – | – | 0.01% | 331 |
|
|
2015
Q2 | $14K | Hold |
209
| – | – | 0.01% | 246 |
|
|
2015
Q1 | $13K | Hold |
209
| – | – | 0.01% | 233 |
|
|
2014
Q4 | $12K | Sell |
209
-117
| -36% | -$6.6K | 0.01% | 271 |
|
|
2014
Q3 | $17K | Sell |
326
-1,056
| -76% | -$52.7K | 0.01% | 367 |
|
|
2014
Q2 | $67K | Buy |
1,382
+932
| +207% | +$45.9K | 0.03% | 197 |
|
|
2014
Q1 | $23K | Sell |
450
-5,872
| -93% | -$312K | 0.01% | 297 |
|
|
2013
Q4 | $336K | Buy |
6,322
+319
| +5% | +$16.3K | 0.12% | 103 |
|
|
2013
Q3 | $278K | Buy |
6,003
+1
| +0% | +$44 | 0.14% | 75 |
|
|
2013
Q2 | $268K | Buy |
+6,002
| New | +$261K | 0.15% | 75 |
|
Other funds holding BMY
VCM
VPM
Waverly Advisors's BMY Position: Q1 2026 in Review
Waverly Advisors increased its Bristol-Myers Squibb (BMY) stake by 50% in Q1 2026, buying an estimated $1.66M and bringing the position to 85,970 shares worth $5.21M. The position accounts for 0.04% of the portfolio, ranked #402.
Waverly Advisors first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Waverly Advisors held 85,970 shares of Bristol-Myers Squibb worth $5.21M as of Q1 2026.
- Waverly Advisors bought 28,502 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.66M.
- Bristol-Myers Squibb made up 0.04% of Waverly Advisors's portfolio in Q1 2026, its #402 holding.
- Waverly Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.